HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Early collaboration with psycho-oncologists can make ‘meaningful difference’ in reducing suicide risk
-
- Should cancer clinical trial eligibility regarding mental illness be relaxed?
- Rousseau’s social contract, vulnerable children, toothless tigers ... and us Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- Bisphosphonates underused among older patients with myeloma
- Venetoclax plus R-CHOP improves outcomes among certain patients with diffuse large B-cell lymphoma
- Low-dose rituximab reduces exacerbation, refractory disease in acquired thrombotic thrombocytopenic purpura
- One year of trastuzumab remains standard for HER2-positive early-stage breast cancer
- Addition of pembrolizumab to chemotherapy demonstrates promise in triple-negative breast cancer
- Researchers identify gene alterations linked to certain metastatic breast cancers
-
- Lifestyle intervention improves outcomes for some breast cancer survivors
- Prolonged ADT may improve survival in high-Gleason grade prostate cancer
- Invasive lung cancer surgery may increase risk for long-term opioid use
- Accredited hospitals vary in quality of head, neck cancer care
- Emergency colon cancer surgery conducted over weekend has poorer outcomes
- FDA approves Lynparza, companion diagnostic for BRCA-mutated ovarian cancer